CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0%

Compliant submissions 0

Incompliant submissions 0

Total trials 0

My Organizations' Clinical Trials

Showing 50 of 518 entries

View as:

Feasibility Study of a Percutaneous Mitral Valve Repair System.

Phase: N/A Priority: Normal

NCT ID: NCT00209339 Org: User:

Start: 07/31/03 End: 10/31/11 Due: 10/31/12

SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation) Study

Phase: N/A Priority: Normal

NCT ID: NCT01990287 Org: User:

Start: 11/30/13 End: 02/29/16 Due: 02/28/17

Post Market (Libra/LibraXP System) Deep Brain Stimulation (DBS) Parkinson's Disease Study

Phase: N/A Priority: Normal

NCT ID: NCT01352819 Org: User:

Start: 05/31/11 End: 12/31/13 Due: 12/31/14

Assessment of the St Jude Medical Portico Resheathable Aortic Valve System-Alternative Access

Phase: N/A Priority: Normal

NCT ID: NCT03056573 Org: User:

Start: 03/29/17 End: 07/05/19 Due: 07/05/20

Safety Study on Stopping Anticoagulation Medication in Patients With a History of Atrial Fibrillation

Phase: N/A Priority: Normal

NCT ID: NCT01650298 Org: User:

Start: 01/31/13 End: 08/31/17 Due: 08/31/18

Observational Study to Evaluate PAD Treatment Clinical and Economic Outcomes

Phase: N/A Priority: Normal

NCT ID: NCT01855412 Org: User:

Start: 05/31/13 End: 04/11/19 Due: 04/11/20

Dependence of LV Hemodynamics on Pacing Site

Phase: N/A Priority: Normal

NCT ID: NCT01564173 Org: User:

Start: 06/30/12 End: 03/31/16 Due: 03/31/17

Artificial Valve Endocarditis Reduction Trial

Phase: N/A Priority: Normal

NCT ID: NCT00590889 Org: User:

Start: 07/31/98 End: 09/30/14 Due: 09/30/15

CardioMEMS HF System Coverage with Evidence Development Study

Phase: N/A Priority: Normal

NCT ID: NCT06779552 Org: User:

Start: 02/07/25 End: 03/31/32 Due: 03/31/33

HeartMate 3™ CE Mark Clinical Investigation Plan

Phase: N/A Priority: Normal

NCT ID: NCT02170363 Org: User:

Start: 06/30/14 End: 03/09/20 Due: 03/09/21

DAVID II (Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial II)

Phase: N/A Priority: Normal

NCT ID: NCT00187187 Org: User:

Start: 06/30/03 End: 09/30/07 Due: 09/30/08

Amplatzer Amulet China Post Market Study (PMS)

Phase: N/A Priority: Normal

NCT ID: NCT06189365 Org: User:

Start: 01/30/24 End: 01/31/30 Due: 01/31/31

JETi Hong Kong Post Market Study (PMS)

Phase: N/A Priority: Normal

NCT ID: NCT06340763 Org: User:

Start: 08/07/24 End: 02/15/25 Due: 02/15/26

FlexNav EU CE Mark Study

Phase: N/A Priority: Normal

NCT ID: NCT03724812 Org: User:

Start: 02/26/19 End: 02/10/21 Due: 02/10/22

Traumatic Brain Injury Peripheral Nerve Study

Phase: N/A Priority: Normal

NCT ID: NCT01588691 Org: User:

Start: 12/31/11 End: 11/30/14 Due: 11/30/15

EnSite Real-Time Cardiac Performance Measurements (RT CPM) Study

Phase: N/A Priority: Normal

NCT ID: NCT00632450 Org: User:

Start: 12/31/07 End: 10/31/08 Due: 10/31/09

EP Device Registry

Phase: N/A Priority: Normal

NCT ID: NCT04460209 Org: User:

Start: 06/12/20 End: 12/31/31 Due: 12/31/32

A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF:

Phase: N/A Priority: Normal

NCT ID: NCT06676072 Org: User:

Start: 11/22/24 End: 04/30/26 Due: 04/30/27

Trial to Evaluate the Safety & Efficacy of the Omnilink Elite™ Peripheral Balloon-Expandable Stent System in Subjects With Atherosclerotic de Novo or Restenotic Lesions in the Native Common Iliac Artery and/or Native External Iliac Artery

Phase: N/A Priority: Normal

NCT ID: NCT01396525 Org: User:

Start: 03/31/09 End: 06/30/14 Due: 06/30/15

Device-based QRS Evaluation

Phase: N/A Priority: Normal

NCT ID: NCT02814214 Org: User:

Start: 06/30/16 End: 09/30/17 Due: 09/30/18

To Study the Safety and Clinical Outcomes of the Absorb Bioresorbable Vascular Scaffold (BVS) System in Patients With de Novo Lesions in Previously Untreated Vessels

Phase: N/A Priority: Normal

NCT ID: NCT01977534 Org: User:

Start: 01/31/14 End: 10/31/18 Due: 10/31/19

SPIRIT FIRST Clinical Trial of the Abbott Vascular XIENCE V® Everolimus Eluting Coronary Stent System

Phase: N/A Priority: Normal

NCT ID: NCT00180453 Org: User:

Start: 12/31/03 End: 06/30/09 Due: 06/30/10

MultiPoint Pacing Mapping Study

Phase: N/A Priority: Normal

NCT ID: NCT02547207 Org: User:

Start: 12/31/15 End: 10/31/18 Due: 10/31/19

The AMPLATZER™ Post-infarct Muscular VSD Occluder Humanitarian Device Exemption (H070005) Post Approval Study

Phase: N/A Priority: Normal

NCT ID: NCT03165526 Org: User:

Start: 10/01/18 End: 11/29/21 Due: 11/29/22

Response of Cardiac Resynchronization Therapy Optimization With Ventricle to Ventricle Timing in Heart Failure Patients

Phase: N/A Priority: Normal

NCT ID: NCT00187200 Org: User:

Start: 01/31/05 End: 04/30/10 Due: 04/30/11

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Feasibility Study of a Percutaneous Mitral Valve Repair System.	NCT00209339	Abbott Medical Devices	user2@example.com	None	2003-07-31	2011-10-31	2012-10-31	-	-	2025-07-14
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation) Study	NCT01990287	Abbott Medical Devices	user2@example.com	None	2013-11-30	2016-02-29	2017-02-28	-	-	2025-07-14
Post Market (Libra/LibraXP System) Deep Brain Stimulation (DBS) Parkinson's Disease Study	NCT01352819	Abbott Medical Devices	user2@example.com	None	2011-05-31	2013-12-31	2014-12-31	-	-	2025-07-14
Assessment of the St Jude Medical Portico Resheathable Aortic Valve System-Alternative Access	NCT03056573	Abbott Medical Devices	user2@example.com	None	2017-03-29	2019-07-05	2020-07-05	-	-	2025-07-14
Safety Study on Stopping Anticoagulation Medication in Patients With a History of Atrial Fibrillation	NCT01650298	Abbott Medical Devices	user2@example.com	None	2013-01-31	2017-08-31	2018-08-31	-	-	2025-07-14
Observational Study to Evaluate PAD Treatment Clinical and Economic Outcomes	NCT01855412	Abbott Medical Devices	user2@example.com	None	2013-05-31	2019-04-11	2020-04-11	-	-	2025-07-14
Dependence of LV Hemodynamics on Pacing Site	NCT01564173	Abbott Medical Devices	user2@example.com	None	2012-06-30	2016-03-31	2017-03-31	-	-	2025-07-14
Artificial Valve Endocarditis Reduction Trial	NCT00590889	Abbott Medical Devices	user2@example.com	None	1998-07-31	2014-09-30	2015-09-30	-	-	2025-07-14
CardioMEMS HF System Coverage with Evidence Development Study	NCT06779552	Abbott Medical Devices	user2@example.com	None	2025-02-07	2032-03-31	2033-03-31	-	-	2025-07-14
HeartMate 3™ CE Mark Clinical Investigation Plan	NCT02170363	Abbott Medical Devices	user2@example.com	None	2014-06-30	2020-03-09	2021-03-09	-	-	2025-07-14
DAVID II (Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial II)	NCT00187187	Abbott Medical Devices	user2@example.com	None	2003-06-30	2007-09-30	2008-09-30	-	-	2025-07-14
Amplatzer Amulet China Post Market Study (PMS)	NCT06189365	Abbott Medical Devices	user2@example.com	None	2024-01-30	2030-01-31	2031-01-31	-	-	2025-07-14
JETi Hong Kong Post Market Study (PMS)	NCT06340763	Abbott Medical Devices	user2@example.com	None	2024-08-07	2025-02-15	2026-02-15	-	-	2025-07-14
FlexNav EU CE Mark Study	NCT03724812	Abbott Medical Devices	user2@example.com	None	2019-02-26	2021-02-10	2022-02-10	-	-	2025-07-14
Traumatic Brain Injury Peripheral Nerve Study	NCT01588691	Abbott Medical Devices	user2@example.com	None	2011-12-31	2014-11-30	2015-11-30	-	-	2025-07-14
EnSite Real-Time Cardiac Performance Measurements (RT CPM) Study	NCT00632450	Abbott Medical Devices	user2@example.com	None	2007-12-31	2008-10-31	2009-10-31	-	-	2025-07-14
EP Device Registry	NCT04460209	Abbott Medical Devices	user2@example.com	None	2020-06-12	2031-12-31	2032-12-31	-	-	2025-07-14
A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF:	NCT06676072	Abbott Medical Devices	user2@example.com	None	2024-11-22	2026-04-30	2027-04-30	-	-	2025-07-14
Trial to Evaluate the Safety & Efficacy of the Omnilink Elite™ Peripheral Balloon-Expandable Stent System in Subjects With Atherosclerotic de Novo or Restenotic Lesions in the Native Common Iliac Artery and/or Native External Iliac Artery	NCT01396525	Abbott Medical Devices	user2@example.com	None	2009-03-31	2014-06-30	2015-06-30	-	-	2025-07-14
Device-based QRS Evaluation	NCT02814214	Abbott Medical Devices	user2@example.com	None	2016-06-30	2017-09-30	2018-09-30	-	-	2025-07-14
To Study the Safety and Clinical Outcomes of the Absorb Bioresorbable Vascular Scaffold (BVS) System in Patients With de Novo Lesions in Previously Untreated Vessels	NCT01977534	Abbott Medical Devices	user2@example.com	None	2014-01-31	2018-10-31	2019-10-31	-	-	2025-07-14
SPIRIT FIRST Clinical Trial of the Abbott Vascular XIENCE V® Everolimus Eluting Coronary Stent System	NCT00180453	Abbott Medical Devices	user2@example.com	None	2003-12-31	2009-06-30	2010-06-30	-	-	2025-07-14
MultiPoint Pacing Mapping Study	NCT02547207	Abbott Medical Devices	user2@example.com	None	2015-12-31	2018-10-31	2019-10-31	-	-	2025-07-14
The AMPLATZER™ Post-infarct Muscular VSD Occluder Humanitarian Device Exemption (H070005) Post Approval Study	NCT03165526	Abbott Medical Devices	user2@example.com	None	2018-10-01	2021-11-29	2022-11-29	-	-	2025-07-14
Response of Cardiac Resynchronization Therapy Optimization With Ventricle to Ventricle Timing in Heart Failure Patients	NCT00187200	Abbott Medical Devices	user2@example.com	None	2005-01-31	2010-04-30	2011-04-30	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance